ID

36684

Descripción

Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR); ODM derived from: https://clinicaltrials.gov/show/NCT02293733

Link

https://clinicaltrials.gov/show/NCT02293733

Palabras clave

Versiones (1)
  1. 1/6/19 1/6/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

1 de junio de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility NSCLC Non Small Cells Lung Cancer NCT02293733

Inglés

Eligibility NSCLC Non Small Cells Lung Cancer NCT02293733

1 formularios  
Eligibility Criteria
Descripción

Eligibility Criteria

inclusion criteria:
Descripción

Inclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1512693
nsclc patients with activating mutations of egfr
Descripción

Non-Small Cell Lung Carcinoma | EGFR Activating Mutation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2]
C2984891
first-line treatment with a tki monotherapy
Descripción

First line treatment Tyrosine kinase inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C1268567
measurable lesion according to recist 1.1
Descripción

Measurable lesion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
age> 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
secondary or acquired resistance of egfr tkis according to the jackman criteria
Descripción

Resistance Secondary EGFR TKI | Resistance Acquired EGFR TKI

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013203
UMLS CUI [1,2]
C0175668
UMLS CUI [1,3]
C1443775
UMLS CUI [2,1]
C0013203
UMLS CUI [2,2]
C0439661
UMLS CUI [2,3]
C1443775
patients for whom it was started a tki treatment in first line from january 2010 until june 2012 (patients who received 1 chemotherapy cycle could be included).
Descripción

First line treatment Tyrosine kinase inhibitor | Chemotherapy cycle Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C1268567
UMLS CUI [2,1]
C1302181
UMLS CUI [2,2]
C1265611
exclusion criteria:
Descripción

Exclusion Criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
patients with small cell carcinoma
Descripción

Carcinoma, Small Cell

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0262584
patients without egfr mutation
Descripción

EGFR mutation Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3266992
UMLS CUI [1,2]
C0332197
patients not treated with egfr tki in first line treatment
Descripción

First line treatment EGFR Tyrosine kinase inhibitor Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C1443775
UMLS CUI [1,3]
C0332197
not measurable lesion to recist 1.1
Descripción

Measurable lesion Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0332197
Volver a la parte superior de la página

Similar models

Eligibility NSCLC Non Small Cells Lung Cancer NCT02293733

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Inclusion criteria
Item
inclusion criteria:
boolean
C1512693 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma | EGFR Activating Mutation
Item
nsclc patients with activating mutations of egfr
boolean
C0007131 (UMLS CUI [1])
C2984891 (UMLS CUI [2])
First line treatment Tyrosine kinase inhibitor
Item
first-line treatment with a tki monotherapy
boolean
C1708063 (UMLS CUI [1,1])
C1268567 (UMLS CUI [1,2])
Measurable lesion
Item
measurable lesion according to recist 1.1
boolean
C1513041 (UMLS CUI [1])
Age
Item
age> 18 years
boolean
C0001779 (UMLS CUI [1])
Resistance Secondary EGFR TKI | Resistance Acquired EGFR TKI
Item
secondary or acquired resistance of egfr tkis according to the jackman criteria
boolean
C0013203 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
C1443775 (UMLS CUI [1,3])
C0013203 (UMLS CUI [2,1])
C0439661 (UMLS CUI [2,2])
C1443775 (UMLS CUI [2,3])
First line treatment Tyrosine kinase inhibitor | Chemotherapy cycle Quantity
Item
patients for whom it was started a tki treatment in first line from january 2010 until june 2012 (patients who received 1 chemotherapy cycle could be included).
boolean
C1708063 (UMLS CUI [1,1])
C1268567 (UMLS CUI [1,2])
C1302181 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Exclusion Criteria
Item
exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
Carcinoma, Small Cell
Item
patients with small cell carcinoma
boolean
C0262584 (UMLS CUI [1])
EGFR mutation Absent
Item
patients without egfr mutation
boolean
C3266992 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
First line treatment EGFR Tyrosine kinase inhibitor Absent
Item
patients not treated with egfr tki in first line treatment
boolean
C1708063 (UMLS CUI [1,1])
C1443775 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Measurable lesion Absent
Item
not measurable lesion to recist 1.1
boolean
C1513041 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial